KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Gross Margin: 2009-2025

Historic Gross Margin for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 33.70%.

  • Quest Diagnostics' Gross Margin rose 110.00% to 33.70% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.30%, marking a year-over-year increase of 57.00%. This contributed to the annual value of 32.86% for FY2024, which is 14.00% down from last year.
  • Per Quest Diagnostics' latest filing, its Gross Margin stood at 33.70% for Q3 2025, which was down 1.33% from 34.15% recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Gross Margin ranged from a high of 40.22% in Q1 2021 and a low of 32.17% during Q4 2023.
  • Over the past 3 years, Quest Diagnostics' median Gross Margin value was 32.85% (recorded in 2023), while the average stood at 33.08%.
  • Its Gross Margin has fluctuated over the past 5 years, first skyrocketed by 992bps in 2021, then crashed by 490bps in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Gross Margin stood at 37.39% in 2021, then slumped by 490bps to 32.49% in 2022, then slumped by 32bps to 32.17% in 2023, then surged by 57bps to 32.74% in 2024, then spiked by 110bps to 33.70% in 2025.
  • Its Gross Margin stands at 33.70% for Q3 2025, versus 34.15% for Q2 2025 and 32.54% for Q1 2025.